Our findings suggest that plasma levels of Gal1 and particularly Gal9 are generally elevated in IMIDs compared to HD, with galectin levels influenced by disease activity in both cases and by disease duration in the case of Gal1. This evidence concerns the gene LGALS9 and Huntington disease.